Intas Pharmaceuticals (10 ANDAs for the US Market) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Intas Pharmaceuticals (10 ANDAs for the US Market) General Information

Description

A portfolio of 10 Abbreviated New Drug Applications (ANDAs) for the U.S. market. The portfolio includes generic products in female hormones that will be manufactured in female hormone facilities in India and commercialized.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Ahmedabad, Gujarat
  • India
Primary Industry
Buildings and Property
Corporate Office
  • Ahmedabad, Gujarat
  • India

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intas Pharmaceuticals (10 ANDAs for the US Market) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Intas Pharmaceuticals (10 ANDAs for the US Market)‘s full profile, request access.

Request a free trial

Intas Pharmaceuticals (10 ANDAs for the US Market) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Intas Pharmaceuticals (10 ANDAs for the US Market)‘s full profile, request access.

Request a free trial

Intas Pharmaceuticals (10 ANDAs for the US Market) FAQs

  • Where is Intas Pharmaceuticals (10 ANDAs for the US Market) headquartered?

    Intas Pharmaceuticals (10 ANDAs for the US Market) is headquartered in Ahmedabad, India.

  • What industry is Intas Pharmaceuticals (10 ANDAs for the US Market) in?

    Intas Pharmaceuticals (10 ANDAs for the US Market)’s primary industry is Buildings and Property.

  • Is Intas Pharmaceuticals (10 ANDAs for the US Market) a private or public company?

    Intas Pharmaceuticals (10 ANDAs for the US Market) is a Private company.

  • What is Intas Pharmaceuticals (10 ANDAs for the US Market)’s current revenue?

    The current revenue for Intas Pharmaceuticals (10 ANDAs for the US Market) is .

  • Who are Intas Pharmaceuticals (10 ANDAs for the US Market)’s investors?

    Intas Pharmaceuticals has invested in Intas Pharmaceuticals (10 ANDAs for the US Market).

  • When was Intas Pharmaceuticals (10 ANDAs for the US Market) acquired?

    Intas Pharmaceuticals (10 ANDAs for the US Market) was acquired on 12-Jun-2020.

  • Who acquired Intas Pharmaceuticals (10 ANDAs for the US Market)?

    Intas Pharmaceuticals (10 ANDAs for the US Market) was acquired by Naari Pharma India.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process